Acute Ischemic Stroke Therapy in Infective Endocarditis: Case Series and Systematic Review

Robert J. Marquardt, Sung-Min Cho, Prateek Thatikunta, Abhishek Deshpande, Dolora Wisco, Ken Uchino

Research output: Contribution to journalArticle

Abstract

Objectives: To evaluate the safety of acute ischemic stroke (AIS) therapy in patients with infective endocarditis (IE) with intravenous thrombolysis (IVT) or endovascular therapy (EVT) such as mechanical thrombectomy. Methods: We conducted a retrospective study of patients who underwent AIS therapy with IVT or EVT at a tertiary referral center from 2013 to 2017, that were later diagnosed with acute IE as the causative mechanism. We then performed a systematic review of reports of acute ischemic reperfusion therapy in IE since 1995 for their success rates in terms of neurological outcome, and mortality, and their risk of hemorrhagic complication. Results: In the retrospective portion, 8 participants met criteria, of whom 4 received IVT and 4 received EVT. Through systematic review, 24 publications of 32 participants met criteria. Combined, a total of 40 participants were analyzed: 18 received IVT alone, 1 received combined IVT plus EVT, and 21 received EVT alone. IVT compared to EVT were similar in rates of good neurologic outcomes (58% versus 76%, P= .22) and mortality (21% versus 19%, P= .87), but had higher post-therapy intracranial hemorrhage (63% versus 18% [P= .006]). Conclusion: IV thrombolysis has a higher rate of post-therapy intracranial hemorrhage compared to EVT. EVT should be considered as first-line AIS therapy for patients with known, or suspected, IE who present with a large vessel occlusion.

Original languageEnglish (US)
Pages (from-to)2207-2212
Number of pages6
JournalJournal of Stroke and Cerebrovascular Diseases
Volume28
Issue number8
DOIs
StatePublished - Aug 1 2019

Fingerprint

Endocarditis
Stroke
Therapeutics
Intracranial Hemorrhages
Thrombectomy
Mortality
Tertiary Care Centers
Nervous System
Reperfusion
Publications
Retrospective Studies

Keywords

  • endovascular therapy
  • Infective endocarditis
  • intravenous thrombolysis
  • ischemic stroke

ASJC Scopus subject areas

  • Surgery
  • Rehabilitation
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Acute Ischemic Stroke Therapy in Infective Endocarditis : Case Series and Systematic Review. / Marquardt, Robert J.; Cho, Sung-Min; Thatikunta, Prateek; Deshpande, Abhishek; Wisco, Dolora; Uchino, Ken.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 28, No. 8, 01.08.2019, p. 2207-2212.

Research output: Contribution to journalArticle

Marquardt, Robert J. ; Cho, Sung-Min ; Thatikunta, Prateek ; Deshpande, Abhishek ; Wisco, Dolora ; Uchino, Ken. / Acute Ischemic Stroke Therapy in Infective Endocarditis : Case Series and Systematic Review. In: Journal of Stroke and Cerebrovascular Diseases. 2019 ; Vol. 28, No. 8. pp. 2207-2212.
@article{82c99f03c44d4ee3a05ab6c7935d485f,
title = "Acute Ischemic Stroke Therapy in Infective Endocarditis: Case Series and Systematic Review",
abstract = "Objectives: To evaluate the safety of acute ischemic stroke (AIS) therapy in patients with infective endocarditis (IE) with intravenous thrombolysis (IVT) or endovascular therapy (EVT) such as mechanical thrombectomy. Methods: We conducted a retrospective study of patients who underwent AIS therapy with IVT or EVT at a tertiary referral center from 2013 to 2017, that were later diagnosed with acute IE as the causative mechanism. We then performed a systematic review of reports of acute ischemic reperfusion therapy in IE since 1995 for their success rates in terms of neurological outcome, and mortality, and their risk of hemorrhagic complication. Results: In the retrospective portion, 8 participants met criteria, of whom 4 received IVT and 4 received EVT. Through systematic review, 24 publications of 32 participants met criteria. Combined, a total of 40 participants were analyzed: 18 received IVT alone, 1 received combined IVT plus EVT, and 21 received EVT alone. IVT compared to EVT were similar in rates of good neurologic outcomes (58{\%} versus 76{\%}, P= .22) and mortality (21{\%} versus 19{\%}, P= .87), but had higher post-therapy intracranial hemorrhage (63{\%} versus 18{\%} [P= .006]). Conclusion: IV thrombolysis has a higher rate of post-therapy intracranial hemorrhage compared to EVT. EVT should be considered as first-line AIS therapy for patients with known, or suspected, IE who present with a large vessel occlusion.",
keywords = "endovascular therapy, Infective endocarditis, intravenous thrombolysis, ischemic stroke",
author = "Marquardt, {Robert J.} and Sung-Min Cho and Prateek Thatikunta and Abhishek Deshpande and Dolora Wisco and Ken Uchino",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2019.04.039",
language = "English (US)",
volume = "28",
pages = "2207--2212",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Acute Ischemic Stroke Therapy in Infective Endocarditis

T2 - Case Series and Systematic Review

AU - Marquardt, Robert J.

AU - Cho, Sung-Min

AU - Thatikunta, Prateek

AU - Deshpande, Abhishek

AU - Wisco, Dolora

AU - Uchino, Ken

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Objectives: To evaluate the safety of acute ischemic stroke (AIS) therapy in patients with infective endocarditis (IE) with intravenous thrombolysis (IVT) or endovascular therapy (EVT) such as mechanical thrombectomy. Methods: We conducted a retrospective study of patients who underwent AIS therapy with IVT or EVT at a tertiary referral center from 2013 to 2017, that were later diagnosed with acute IE as the causative mechanism. We then performed a systematic review of reports of acute ischemic reperfusion therapy in IE since 1995 for their success rates in terms of neurological outcome, and mortality, and their risk of hemorrhagic complication. Results: In the retrospective portion, 8 participants met criteria, of whom 4 received IVT and 4 received EVT. Through systematic review, 24 publications of 32 participants met criteria. Combined, a total of 40 participants were analyzed: 18 received IVT alone, 1 received combined IVT plus EVT, and 21 received EVT alone. IVT compared to EVT were similar in rates of good neurologic outcomes (58% versus 76%, P= .22) and mortality (21% versus 19%, P= .87), but had higher post-therapy intracranial hemorrhage (63% versus 18% [P= .006]). Conclusion: IV thrombolysis has a higher rate of post-therapy intracranial hemorrhage compared to EVT. EVT should be considered as first-line AIS therapy for patients with known, or suspected, IE who present with a large vessel occlusion.

AB - Objectives: To evaluate the safety of acute ischemic stroke (AIS) therapy in patients with infective endocarditis (IE) with intravenous thrombolysis (IVT) or endovascular therapy (EVT) such as mechanical thrombectomy. Methods: We conducted a retrospective study of patients who underwent AIS therapy with IVT or EVT at a tertiary referral center from 2013 to 2017, that were later diagnosed with acute IE as the causative mechanism. We then performed a systematic review of reports of acute ischemic reperfusion therapy in IE since 1995 for their success rates in terms of neurological outcome, and mortality, and their risk of hemorrhagic complication. Results: In the retrospective portion, 8 participants met criteria, of whom 4 received IVT and 4 received EVT. Through systematic review, 24 publications of 32 participants met criteria. Combined, a total of 40 participants were analyzed: 18 received IVT alone, 1 received combined IVT plus EVT, and 21 received EVT alone. IVT compared to EVT were similar in rates of good neurologic outcomes (58% versus 76%, P= .22) and mortality (21% versus 19%, P= .87), but had higher post-therapy intracranial hemorrhage (63% versus 18% [P= .006]). Conclusion: IV thrombolysis has a higher rate of post-therapy intracranial hemorrhage compared to EVT. EVT should be considered as first-line AIS therapy for patients with known, or suspected, IE who present with a large vessel occlusion.

KW - endovascular therapy

KW - Infective endocarditis

KW - intravenous thrombolysis

KW - ischemic stroke

UR - http://www.scopus.com/inward/record.url?scp=85065872837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065872837&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2019.04.039

DO - 10.1016/j.jstrokecerebrovasdis.2019.04.039

M3 - Article

C2 - 31129109

AN - SCOPUS:85065872837

VL - 28

SP - 2207

EP - 2212

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 8

ER -